We are currently working on a new vaccine platform involving synthetic protease-resistant B cell epitopes. We are also studying immunotoxins and completing the development of our ricin vaccine. RiVax.

Skills and expertise(26) View all

77 Following View all

162 Followers View all

We use cookies to give you the best possible experience on ResearchGate. Read our cookies policy to learn more.